Omega Therapeutics
Designing, engineering and manufacturing Epigenomic Controllers
At Omega Therapeutics, we interrogate the central dogma to target the biological root of disease and change its course without altering nucleic acid sequences or the genetic code.
We are focused on precision tuning to activate the human genome’s native capacity to treat and cure diseases — ultimately allowing for the advancement of medicine and a new future of disease management.
Visit website: https://omegatherapeutics.com/
Details last updated 02-Aug-2020
Omega Therapeutics News
MIT professor Richard Young explains how Omega regulates gene expression
Cell and gene - 01-Dec-2020
Using Epigenomic Controllers to alter DNA transcription rather than the genes themselves
Read more...Omega Therapeutics raises $85m for Epigenomic Controllers
Endpoints News - 29-Jul-2020
New gene expression therapy for various targets, with clinical trial planned for 2021
Read more...